Why the study?
With the expanding use of ECMO for cardiopulmonary failure, this study aimed to characterize maternal and fetal survival and ECMO-related complications in peripartum patients.
Population
21 consecutive pregnant or postpartum patients requiring VV or VA ECMO at a single quaternary referral center
Comparison
VV ECMO vs VA ECMO
Design
Single-center case series
Authors
Loading...
Hypothesis-generating for ECMO in peripartum cardiopulmonary failure; prospective studies needed before practice change.
ECMO is a viable rescue therapy for peripartum patients with cardiopulmonary failure, demonstrating excellent maternal and neonatal survival despite a high rate of bleeding complications.
Lankford et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: